Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization

References

• Gerdes GH. Rift Valley fever. Rev Sci Tech 2004; 23:613 - 623
   PubMed Web of Science ®Google Scholar
• Moutailler S, Krida G, Schaffner F, Vazeille M, Failloux AB. Potential vectors of Rift Valley fever virus in the Mediterranean region. Vector Borne Zoonotic Dis 2008; 8:749 - 753
   PubMed Web of Science ®Google Scholar
• López-Vélez R, Molina R. Climate change in Spain and risk of infectious and parasitic diseases transmitted by arthropods and rodents. Rev Esp Salud Pública 2005; 79:177 - 190
   PubMedGoogle Scholar
• Coetzer JA, Ishak KG. Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus I. Macroscopic and microscopic pathology. Onderstepoort J Vet Res 1982; 49:103 - 108
   PubMed Web of Science ®Google Scholar
• Coetzer JA, Ishak KG, Calvert RC. Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus II. Ultrastructural findings. Onderstepoort J Vet Res 1982; 49:109 - 122
   PubMed Web of Science ®Google Scholar
• Arthur RR, el-Sharkawy MS, Cope SE, Botros BA, Oun S, Morrill JC, et al. Recurrence of Rift Valley fever in Egypt. Lancet 1993; 342:1149 - 1150
   PubMed Web of Science ®Google Scholar
• Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Bushra A, et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 2003; 36:245 - 252
   PubMed Web of Science ®Google Scholar
• Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ. Rift Valley fever virus. J Am Vet Med Assoc 2009; 234:883 - 893
   PubMed Web of Science ®Google Scholar
• Evans A, Gakuya F, Paweska JT, Rostal M, Akoolo L, Van Vuren PJ, et al. Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife. Epidemiol Infect 2008; 136:1261 - 1269
   PubMed Web of Science ®Google Scholar
• Paweska JT, van Vuren PJ, Kemp A, Buss P, Bengis RG, Gakuya F, et al. Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo. Vet Microbiol 2008; 127:21 - 28
   PubMed Web of Science ®Google Scholar
• Paweska JT, Mortimer E, Leman PA, Swanepoel R. An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants. J Virol Methods 2005; 127:10 - 18
   PubMed Web of Science ®Google Scholar
• Flick R, Bouloy M. Rift Valley fever virus. Curr Mol Med 2005; 5:827 - 834
   PubMed Web of Science ®Google Scholar
• Le May N, Gauliard N, Billecocq A, Bouloy M. The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization. J Virol 2005; 79:11974 - 11980
   PubMed Web of Science ®Google Scholar
• Koser ML, McGettigan JP, Tan GS, Smith ME, Koprowski H, Dietzschold B, Schnell MJ. Rabies virus nucleoprotein as a carrier for foreign antigens. Proc Natl Acad Sci USA 2004; 101:9405 - 9410
   PubMed Web of Science ®Google Scholar
• Mebatsion T, Koolen MJ, de Vaan LT, de Haas N, Braber M, Romer-Oberdorfer A, et al. Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J Virol 2002; 76:10138 - 10146
   PubMed Web of Science ®Google Scholar
• Gould EA, Higgs S. Impact of climate change and other factors on emerging arbovirus diseases. Trans R Soc Trop Med Hyg 2009; 103:109 - 121
   PubMed Web of Science ®Google Scholar
• Paweska JT, Jansen van Vuren P, Swanepoel R. Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans. J Virol Methods 2007; 146:119 - 124
   PubMed Web of Science ®Google Scholar
• Jansen van Vuren P, Potgieter AC, Paweska JT, van Dijk AA. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. J Virol Methods 2007; 140:106 - 114
   PubMed Web of Science ®Google Scholar
• Meegan JM, Digoutte JP, Peters CJ, Shope RE. Monoclonal antibodies to identify Zinga virus as Rift Valley Fever virus. Lancet 1983; 1:641
   PubMed Web of Science ®Google Scholar
• Besselaar TG, Blackburn NK, Meenehan GM. Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains. Res Virol 1991; 142:469 - 474
   PubMedGoogle Scholar
• Besselaar TG, Blackburn NK. Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies. Arch Virol 1991; 121:111 - 124
   PubMed Web of Science ®Google Scholar
• Blackburn NK, Besselaar TG. A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies. J Virol Methods 1991; 33:367 - 374
   PubMed Web of Science ®Google Scholar
• Besselaar TG, Blackburn NK. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins. Arch Virol 1992; 125:239 - 250
   PubMed Web of Science ®Google Scholar
• Besselaar TG, Blackburn NK. The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity. Res Virol 1994; 145:13 - 19
   PubMedGoogle Scholar
• Zaki A, Coudrier D, Yousef AI, Fakeeh M, Bouloy M, Billecocq A. Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera. J Virol Methods 2006; 131:34 - 40
   PubMed Web of Science ®Google Scholar
• Caplen H, Peters CJ, Bishop DH. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 1985; 66:2271 - 2277
   PubMed Web of Science ®Google Scholar
• Lorenzo G, Martin-Folgar R, Rodriguez F, Brun A. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep. Vaccine 2008; 26:5255 - 5262
   PubMed Web of Science ®Google Scholar
• Galfre G, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981; 73:3 - 46
   PubMedGoogle Scholar